This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Insulin-like growth factor
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 8: | Line 8: | ||
== Relevance == | == Relevance == | ||
Inhibition of IGF I influences colon cancer<ref>PMID:11694656</ref>. IGF I has protective effect in neuropathy<ref>PMID:15832492</ref>. | Inhibition of IGF I influences colon cancer<ref>PMID:11694656</ref>. IGF I has protective effect in neuropathy<ref>PMID:15832492</ref>. | ||
| + | |||
| + | See also [[Insulin-like growth factor receptor]] and [[Insulin-like growth factor 1]]. | ||
</StructureSection> | </StructureSection> | ||
| Line 15: | Line 17: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *IGF I | + | *IGF I residues 49-118 |
| - | **[[2gf1]], [[3gf1]], [[1b9g]], [[1bqt]] – hIGF I – human – NMR<BR /> | + | **[[2gf1]], [[3gf1]], [[1b9g]], [[1bqt]], [[6rva]] – hIGF I – human – NMR<BR /> |
**[[3lri]] - hIGF I (mutant) – NMR<BR /> | **[[3lri]] - hIGF I (mutant) – NMR<BR /> | ||
| - | **[[1tgr]] - hIGF I (mutant) <BR /> | ||
**[[1imx]], [[1gzr]], [[1gzy]], [[1gzz]], [[1h02]] - hIGF I<BR /> | **[[1imx]], [[1gzr]], [[1gzy]], [[1gzz]], [[1h02]] - hIGF I<BR /> | ||
| + | **[[1tgr]] - hIGF I (mutant) <BR /> | ||
**[[1pmx]] – hIGF I + peptide - NMR<BR /> | **[[1pmx]] – hIGF I + peptide - NMR<BR /> | ||
**[[1h59]] – hIGF I + IGF binding protein 5<BR /> | **[[1h59]] – hIGF I + IGF binding protein 5<BR /> | ||
| Line 27: | Line 29: | ||
**[[2dsq]] - hIGF I + IGF binding protein 4 + IGF binding protein 1<br /> | **[[2dsq]] - hIGF I + IGF binding protein 4 + IGF binding protein 1<br /> | ||
**[[4xss]] - hIGF I + insulin receptor + insulin-like growth factor receptor peptide<br /> | **[[4xss]] - hIGF I + insulin receptor + insulin-like growth factor receptor peptide<br /> | ||
| + | **[[5u8q]] - hIGF I + IGFI receptor + antibody<br /> | ||
| + | **[[6ff3]] - hIGF I + neural ectodermal development factor<br /> | ||
| + | **[[6pyh]] - hIGF I + mIGFI receptor – Cryo EM<br /> | ||
| + | **[[7wrq]] - hIGF I + IGFBP3 + ALS – Cryo EM<br /> | ||
| + | **[[7s0q]] - hIGF I + IGFI receptor + insulin receptor – Cryo EM<br /> | ||
| + | **[[8eyr]] - hIGF I 1-195 + IGFI receptor – Cryo EM<br /> | ||
| - | *IGF II | + | *IGF II residues 25-91 |
**[[1igl]], [[5l3l]], [[5l3m]], [[5l3n]] - hIGF II – NMR<BR /> | **[[1igl]], [[5l3l]], [[5l3m]], [[5l3n]] - hIGF II – NMR<BR /> | ||
**[[3e4z]] – hIGF II + insulin-degrading enzyme<BR /> | **[[3e4z]] – hIGF II + insulin-degrading enzyme<BR /> | ||
| - | **[[ | + | **[[3kr3]] - hIGF II + antibody<br /> |
| + | **[[6um2]] - hIGF II + bIGFII receptor – Cryo EM<br /> | ||
| + | **[[6vwg]], [[6vwi]] - hIGF II + IGFI receptor – Cryo EM<br /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Current revision
| |||||||||||
3D structures of insulin-like growth factor
Updated on 17-January-2024
References
- ↑ Wood AW, Duan C, Bern HA. Insulin-like growth factor signaling in fish. Int Rev Cytol. 2005;243:215-85. PMID:15797461 doi:http://dx.doi.org/10.1016/S0074-7696(05)43004-1
- ↑ Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr. 2001 Nov;131(11 Suppl):3109S-20S. PMID:11694656
- ↑ Mohamed-Ali V, Pinkney J. Therapeutic potential of insulin-like growth factor-1 in patients with diabetes mellitus. Treat Endocrinol. 2002;1(6):399-410. PMID:15832492
